🚀 VC round data is live in beta, check it out!

Polyrizon Valuation Multiples

Discover revenue and EBITDA valuation multiples for Polyrizon and similar public comparables like Geratherm Medical, Episurf Medical, Iridex, Inspira Technologies and more.

Polyrizon Overview

About Polyrizon

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.


Founded

2005

HQ

Israel

Employees

6

Financials (FY)

Revenue:
EBITDA: ($5M)

EV

$18M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Polyrizon Financials

Polyrizon reported last fiscal year revenue of — and negative EBITDA of ($5M).

In the same fiscal year, Polyrizon generated ($5M) in EBITDA losses and had net loss of ($3M).


Polyrizon P&L

In the most recent fiscal year, Polyrizon reported revenue of and EBITDA of ($5M).

Polyrizon expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Polyrizon forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDAXXX($5M)XXXXXXXXX
Net ProfitXXX($3M)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Polyrizon Stock Performance

Polyrizon has current market cap of $17M, and enterprise value of $18M.

Market Cap Evolution


Polyrizon's stock price is $10.75.

See Polyrizon trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$18M$17M-4.9%XXXXXXXXX$-2.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Polyrizon Valuation Multiples

Polyrizon trades at (3.3x) EV/EBITDA.

See valuation multiples for Polyrizon and 15K+ public comps

Polyrizon Financial Valuation Multiples

As of April 11, 2026, Polyrizon has market cap of $17M and EV of $18M.

Equity research analysts estimate Polyrizon's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Polyrizon has a P/E ratio of (5.2x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$17MXXX$17MXXXXXXXXX
EV (current)$18MXXX$18MXXXXXXXXX
EV/EBITDAXXX(3.3x)XXXXXXXXX
EV/EBITXXX(3.1x)XXXXXXXXX
P/EXXX(5.2x)XXXXXXXXX
EV/FCFXXX(4.0x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Polyrizon Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Polyrizon Margins & Growth Rates

Polyrizon's revenue in the last fiscal year grew by .

Polyrizon's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.0M for the same period.

See operational valuation multiples for Polyrizon and other 15K+ public comps

Polyrizon Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDA GrowthXXX360%XXXXXXXXX
Revenue per EmployeeXXX$0.0MXXXXXXXXX
Opex per EmployeeXXX$1.0MXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Polyrizon Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Geratherm MedicalXXXXXXXXXXXXXXXXXX
Episurf MedicalXXXXXXXXXXXXXXXXXX
IridexXXXXXXXXXXXXXXXXXX
Inspira TechnologiesXXXXXXXXXXXXXXXXXX
Clinical LaserthermiaXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Polyrizon M&A Activity

Polyrizon acquired XXX companies to date.

Last acquisition by Polyrizon was on XXXXXXXX, XXXXX. Polyrizon acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Polyrizon

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Polyrizon Investment Activity

Polyrizon invested in XXX companies to date.

Polyrizon made its latest investment on XXXXXXXX, XXXXX. Polyrizon invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Polyrizon

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Polyrizon

When was Polyrizon founded?Polyrizon was founded in 2005.
Where is Polyrizon headquartered?Polyrizon is headquartered in Israel.
How many employees does Polyrizon have?As of today, Polyrizon has over 6 employees.
Who is the CEO of Polyrizon?Polyrizon's CEO is Tomer Izraeli.
Is Polyrizon publicly listed?Yes, Polyrizon is a public company listed on Nasdaq.
What is the stock symbol of Polyrizon?Polyrizon trades under PLRZ ticker.
When did Polyrizon go public?Polyrizon went public in 2024.
Who are competitors of Polyrizon?Polyrizon main competitors are Geratherm Medical, Episurf Medical, Iridex, Inspira Technologies.
What is the current market cap of Polyrizon?Polyrizon's current market cap is $17M.
Is Polyrizon profitable?No, Polyrizon is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial